The Global Apheresis Equipment Market is expected to reach US$ 8.11 Bn by 2030, from US$ 3.85 Bn in 2023, exhibiting a CAGR of 11.2% during the forecast period.
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 3.85 Bn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
11.20% |
2030 Value Projection: |
US$ 8.11 Bn |
Figure 1. Global Apheresis Equipment Market Share (%), By Region, 2023
The global apheresis equipment market has been witnessing significant growth in the recent years. Apheresis is a medical technology in which the blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. Some of the main areas where apheresis is applied include blood donation and transfusion medicine. With the rising prevalence of chronic diseases such as cancer that require blood products for treatment, and the growing organ transplantation activities worldwide, the demand for apheresis equipment is surging. Moreover, technological advancements in apheresis platforms that enhance efficiency and automation are expanding the potential scope of applications. The market is thus expected to grow at a healthy pace during the forecast period.
Market Dynamics:
The global apheresis equipment market is driven by factors such as the increasing incidence of blood disorders and the rising need for blood component separation procedures. According to statistics, more than 8 million lives are saved each year through blood transfusions around the world. Furthermore, the aging population that is more prone to chronic diseases, and the growing organ donor programs are fueling the demand for apheresis equipment. However, the market potential can be restricted due to various factors. High costs associated with apheresis procedures and equipment may deter widespread adoption in price-sensitive developing regions. Also, stringent regulations for blood collection and the need for specialized technicians to operate these advanced machines pose market challenges. On the positive side, ongoing technological improvements in automation, efficiency, and user-friendliness of these systems are creating new opportunities.
Key features of the study:
- This report provides an in-depth analysis of the global apheresis equipment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global apheresis equipment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Asahi Kasei Medical Co., Ltd., Terumo Corporation, Inc., Fenwal, Inc., Haemonetics Corp., Therakos, Inc., B. Braun Melsungen AG, HemaCare Corporation, Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Miltenyi Biotec, NxStage Medical, and Kaneka Medix Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global apheresis equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apheresis equipment market
Global Apheresis Equipment Market Detailed Segmentation:
- By Equipment Type:
- Disposable Apheresis Kits
- Apheresis Machines
- By Technology Type:
- Centrifugation
- Membrane Filtration
- By Procedure Type:
- Photopheresis
- Plasmapheresis
- LDL Apheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Others (Lymphopheresis, lipidpheresis)
- By Application:
- Renal disorders
- Neurological disorders
- Hematological disorders
- Other disorders
- By End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Blood Donation Centers
- Others
- By Region:
- Europe
- North America
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Asahi Kasei Medical Co., Ltd.
- Terumo Corporation, Inc.
- Fenwal, Inc.
- Haemonetics Corp.
- Therakos, Inc.
- Braun Melsungen AG
- HemaCare Corporation
- Haemonetics Corporation
- Cerus Corporation
- Kawasumi Laboratories
- Miltenyi Biotec
- NxStage Medical
- Kaneka Medix Corporation.